Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
GeneBankAC: FP929045, FP929046
Faecalibacterium prausnitzii is an abundant gut commensal with potent anti-inflammatory properties mediated through cytokine modulation, tight junction fortification, and epigenetic effects, making it a potential therapeutic target for Inflammatory Bowel Disease (IBD).
It is a member of Clostridium cluster XIVa